0001104659-11-053202.txt : 20110926 0001104659-11-053202.hdr.sgml : 20110926 20110926123645 ACCESSION NUMBER: 0001104659-11-053202 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110922 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20110926 DATE AS OF CHANGE: 20110926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO CENTRAL INDEX KEY: 0000724004 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 840872291 STATE OF INCORPORATION: CO FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11740 FILM NUMBER: 111106743 BUSINESS ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 BUSINESS PHONE: 3039878000 MAIL ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER COMPANY: FORMER CONFORMED NAME: MESA MEDICAL INC DATE OF NAME CHANGE: 19921123 8-K 1 a11-26967_18k.htm 8-K

 

 

U.S. Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

SEPTEMBER 22, 2011

Date of Report (Date of earliest event Reported)

 

MESA LABORATORIES, INC.

(Exact Name of Small Business Issuer as Specified in its Charter)

 

Commission File Number: 0-11740

 

COLORADO

 

84-0872291

(State or other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification No.)

 

12100 WEST SIXTH AVENUE, LAKEWOOD,
COLORADO

 

80228

(Address of Principal Executive Offices)

 

(Zip Code)

 

Issuer’s telephone number, including area code: (303) 987-8000

 

Not Applicable.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

ITEM 5.07   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on September 22, 2011.  Of the 3,281,791 Shares entitled to vote, 2,986,181 were represented either in person or by proxy.  Seven Directors were elected to serve until the next Annual Meeting of Shareholders.  The appointment of Ehrhardt, Keefe, Steiner & Hottman, PC (EKS&H) as the Company’s independent public accountants for fiscal 2012 (the “Ratification of Auditors Proposal”) was approved.

 

The seven directors elected were:

 

 

 

FOR

 

WITHHELD

 

BROKER NON-VOTES

 

Michael T. Brooks

 

2,514,535

 

1,302

 

470,344

 

H. Stuart Campbell

 

2,495,016

 

20,821

 

470,344

 

Robert V. Dwyer

 

2,508,618

 

7,219

 

470,344

 

Evan C. Guillemin

 

2,496,013

 

19,824

 

470,344

 

Luke R. Schmieder

 

2,337,653

 

178,184

 

470,344

 

John J. Sullivan, Ph.D.

 

2,513,935

 

1,902

 

470,344

 

David M. Kelly

 

2,514,535

 

1,302

 

470,344

 

 

The appointment of Ehrhardt, Keefe, Steiner & Hottman, PC (EKS&H) as the Company’s independent public accountants for fiscal 2012 (the “Ratification of Auditors Proposal”) was approved by the following vote:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-VOTES

 

 

 

 

 

 

 

2,967,642

 

17,944

 

595

 

—

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MESA LABORATORIES,

 

 

INC.

 

 

(Issuer)

 

 

 

 

 

 

DATED: September 26, 2011

BY:

/s/ John J. Sullivan, Ph.D.

 

 

John J. Sullivan, Ph.D.

 

 

Chief Executive Officer,

 

 

President and Director

 

3